{"results": [{"id": "0001503802:2013:FY", "start_date": "2013-01-01", "end_date": "2013-12-31", "filing_date": "2014-03-21", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2013", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001047469-14-002800", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001047469-14-002800/files/kpti-20131231.xml", "financials": {"income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -33947000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": 387000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "costs_and_expenses": {"value": 34337000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_tax_expense_benefit": {"value": -33947000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 387000, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -33947000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -33947000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 34337000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -33947000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -33950000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "balance_sheet": {"liabilities_and_equity": {"value": 158226000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 154934000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 270000, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 154934000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 157956000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 3292000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 3292000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_than_fixed_noncurrent_assets": {"value": 30000, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "assets": {"value": 158226000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 240000, "unit": "USD", "label": "Fixed Assets", "order": 400}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -33947000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -33947000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 185930000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 155583000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -30290000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -30290000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 155583000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -57000, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -57000, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 185930000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}, {"id": "0001503802:2014:FY", "start_date": "2014-01-01", "end_date": "2014-12-31", "filing_date": "2015-03-13", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2014", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-15-091264", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-15-091264/files/kpti-20141231.xml", "financials": {"income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "interest_expense_operating": {"value": 1000, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_after_tax": {"value": -75777000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -75777000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 76075000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -75777000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 229000, "unit": "USD", "label": "Revenues", "order": 100}, "income_tax_expense_benefit": {"value": -76326000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 76075000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": 229000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -75777000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -75846000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"noncurrent_liabilities": {"value": 1242000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 13543000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 2754000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "current_assets": {"value": 207751000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 12586000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 206794000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 220337000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 206794000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_than_fixed_noncurrent_assets": {"value": 9832000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "liabilities_and_equity": {"value": 220337000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 12301000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -75806000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -75806000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -75806000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -67031000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -51447000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "exchange_gains_losses": {"value": -8000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities_continuing": {"value": 113121000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -51447000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": -67031000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -5365000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -5373000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 113121000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"id": "0001503802:2015:FY", "start_date": "2015-01-01", "end_date": "2015-12-31", "filing_date": "2016-03-15", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2015", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-16-505181", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-16-505181/files/kpti-20151231.xml", "financials": {"income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_tax_expense_benefit": {"value": -118085000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -118181000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 119326000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -119076000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": 250000, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "nonoperating_income_loss": {"value": 895000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_after_tax": {"value": -118181000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_parent": {"value": -118181000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 250000, "unit": "USD", "label": "Revenues", "order": 100}, "costs_and_expenses": {"value": 119326000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -118181000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -94029000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -94029000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 92700000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -90823000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -92152000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -90823000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "exchange_gains_losses": {"value": -99000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities": {"value": 92700000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -92251000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 15132000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_than_fixed_noncurrent_assets": {"value": 34360000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "liabilities_and_equity": {"value": 215443000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 1946000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 198365000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 198365000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 37843000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 17078000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 215443000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 177600000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 3483000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -118434000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -118434000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -118434000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"id": "0001503802:2016:FY", "start_date": "2016-01-01", "end_date": "2016-12-31", "filing_date": "2017-03-16", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2016", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-17-084396", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-17-084396/files/kpti-20161231.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 51164000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -84391000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -8632000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "exchange_gains_losses": {"value": -63000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow": {"value": -8695000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 24595000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -84391000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 24595000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 51164000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -109569000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -109569000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -109569000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -109577000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 139000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss": {"value": -109577000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "benefits_costs_expenses": {"value": 109592000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -110732000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "nonoperating_income_loss": {"value": 1294000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -109577000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -109438000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -109577000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 110886000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "costs_and_expenses": {"value": 109592000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "revenues": {"value": 154000, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"liabilities": {"value": 18142000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 16476000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 1666000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_than_fixed_noncurrent_assets": {"value": 45913000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "noncurrent_assets": {"value": 48749000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 162243000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 2836000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity": {"value": 162243000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 180385000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 131636000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 180385000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}}}, {"id": "0001503802:2017:FY", "start_date": "2017-01-01", "end_date": "2017-12-31", "filing_date": "2018-03-15", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2017", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-18-084024", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-18-084024/files/kpti-20171231.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -128927000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -128927000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -128927000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"costs_and_expenses": {"value": 130526000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -128984000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 1605000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -128984000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -128984000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -130538000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 132143000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_tax_expense_benefit": {"value": 63000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_before_tax": {"value": -128921000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_before_equity_method_investments": {"value": -128921000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "nonoperating_income_loss": {"value": 1617000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss": {"value": -128984000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "benefits_costs_expenses": {"value": 130526000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "cash_flow_statement": {"exchange_gains_losses": {"value": 200000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_continuing": {"value": 19134000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -73717000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 75743000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -73717000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 17108000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 75743000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 17108000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 19334000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "balance_sheet": {"current_liabilities": {"value": 49467000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 1363000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 2185000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities_and_equity": {"value": 180294000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 148423000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 129464000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 129464000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_than_fixed_noncurrent_assets": {"value": 29686000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "noncurrent_assets": {"value": 31871000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 180294000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 50830000.0, "unit": "USD", "label": "Liabilities", "order": 600}}}}, {"id": "0001503802:2018:FY", "start_date": "2018-01-01", "end_date": "2018-12-31", "filing_date": "2019-02-28", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2018", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-19-057610", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-19-057610/files/kpti-20181231.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": -27000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -178434000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -178434000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"current_liabilities": {"value": 46904000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 183170000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 6580000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 111118000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 158022000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 341192000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 341192000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 334612000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_than_fixed_noncurrent_assets": {"value": 2717000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 183170000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 3863000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 316109000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "exchange_gains_losses": {"value": -78000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities": {"value": 316109000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 49250000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 49328000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -159117000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -107664000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -107664000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -159117000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "income_statement": {"operating_expenses": {"value": 210219000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "interest_expense_operating": {"value": 2493000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_loss_from_continuing_operations_before_tax": {"value": -178381000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -178407000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "nonoperating_income_loss": {"value": 1502000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -178407000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 208717000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_income_loss": {"value": -179883000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -178407000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -178407000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_tax_expense_benefit": {"value": 26000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 30336000.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 208717000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_before_equity_method_investments": {"value": -178381000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}}}}, {"id": "0001503802:2019:FY", "start_date": "2019-01-01", "end_date": "2019-12-31", "filing_date": "2020-02-26", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2019", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-20-049115", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-20-049115/files/d853399d10k_htm.xml", "financials": {"cash_flow_statement": {"exchange_gains_losses": {"value": 19000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities": {"value": 124305000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 78450000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 124305000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 11952000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -190822000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 78450000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -190822000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 11933000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "balance_sheet": {"liabilities_and_equity": {"value": 294963000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 3046000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_liabilities": {"value": 198839000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 294963000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 49774000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 278570000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_than_fixed_noncurrent_assets": {"value": 13347000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "noncurrent_assets": {"value": 16393000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 245189000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 49774000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 46350000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 207000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -199383000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -199383000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"interest_expense_operating": {"value": 15647000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "nonoperating_income_loss": {"value": -10275000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_attributable_to_parent": {"value": -199590000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -199590000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -189275000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 230168000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 240443000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 240443000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "revenues": {"value": 40893000.0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -199550000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_before_equity_method_investments": {"value": -199550000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -199590000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 40000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_after_tax": {"value": -199590000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}}}, {"id": "0001503802:2020:FY", "start_date": "2020-01-01", "end_date": "2020-12-31", "filing_date": "2021-02-24", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2020", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-21-054811", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-21-054811/files/d53064d10k_htm.xml", "financials": {"balance_sheet": {"equity": {"value": 50546000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 313050000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 50546000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_than_fixed_noncurrent_assets": {"value": 34300000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 276531000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 313050000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 262504000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 202301000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 2219000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_assets": {"value": 36519000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 60203000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "cash_flow_statement": {"exchange_gains_losses": {"value": 268000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities": {"value": -53685000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -41836000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -160234000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 172083000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 172083000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -41568000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -53685000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -160234000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -195718000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 555000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -195718000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"operating_income_loss": {"value": -171850000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit_deferred": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "interest_expense_operating": {"value": 27140000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "operating_expenses": {"value": 279935000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -195964000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "costs_and_expenses": {"value": 304049000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -196273000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -196273000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "nonoperating_income_loss": {"value": -24114000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "revenues": {"value": 108085000.0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_before_equity_method_investments": {"value": -195964000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -196273000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -196273000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 304049000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_tax_expense_benefit": {"value": 309000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}}}}, {"id": "0001503802:2021:FY", "start_date": "2021-01-01", "end_date": "2021-12-31", "filing_date": "2022-03-01", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2021", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-002548", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-002548/files/kpti-20211231_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -107116000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 141840000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "exchange_gains_losses": {"value": -48000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities": {"value": -107116000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 73648000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 108372000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 108324000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 73648000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 141840000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "balance_sheet": {"current_assets": {"value": 275606000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": -79673000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 384978000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": -79673000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 305305000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_than_fixed_noncurrent_assets": {"value": 28057000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 311260000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 1642000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities_and_equity": {"value": 305305000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 29699000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 73718000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -124415000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -124415000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -327000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"net_income_loss": {"value": -124088000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit": {"value": 268000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_income_loss": {"value": -98271000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 333639000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_parent": {"value": -124088000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 308090000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -124088000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 333639000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -124088000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -123820000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "nonoperating_income_loss": {"value": -25549000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "interest_expense_operating": {"value": 26046000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 209819000.0, "unit": "USD", "label": "Revenues", "order": 100}}}}], "status": "OK", "request_id": "a0e05487c9edb596f607efeed051e450"}